Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 5, Issue : 4, Year : 2019
Article Page : 529-533
https://doi.org/10.18231/j.ijceo.2019.123
Abstract
Aim: To evaluate the visual outcome and clinical response in CNVM patient after Anti-VEGF treatment.
Material and Methods: This prospective observational study was conducted on 38 diagnosed eye of
CNVM and its presence was confirmed by FFA. Complete ocular examination was conducted with respect
to CNVM. They were followed up post injection (inj.ranibizumab) at day 1,7,1 month and on PRN basis,
change in visual acuity and OCT findings was recorded.
Results: Mean age of study participants were 62.215.9. Majority (63.3%) of the patients were more than
60 years of age. Out of 30 patients 18 were males and 12 were females with M: F ratio 6:4. Difference
in visual acuity at pre and post treatment was significant with p value (<0> difference was found between pre and post treatment macular thickness on OCT (p value <0> Conclusion: Intravitreal ranibizumab injection was beneficial treatment for all type of CNVM administered
on PRN basis over 18 month of follow-up achieved stabilization of vision with significant improvement in
BCVA and decreased retinal thickness by OCT.
Keywords: Optical coherence tomography (OCT), Fundus fluorescence angiography (FFA), Prorenata (PRN).
How to cite : Gour R, Study of choroidal neovascularization and its outcome after anti-vegf treatment. Indian J Clin Exp Ophthalmol 2019;5(4):529-533
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.